Enlivex Therapeutics Ltd. - ADR

Name: Enlivex Therapeutics Ltd. - ADR Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Enlivex Therapeutics Ltd. - ADR

Stock Card

$1.28

$-0.07 (-5.19%)

As on 31-Aug-2026 16:00EDT

Market cap

$24 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

Div. Yield

0 %

Value Research Rating

Quality Score

Growth Score

Valuation Score

Momentum Score

Know more

Explore 5 star rated stocks

Enlivex Therapeutics - ADR Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 1.15 High: 1.34

52 Week Range

Low: 1.15 High: 27.15

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

1.3 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-1.5
Debt to Equity

0
Book Value

$602.2
EPS

$384.5
Face value

--
Shares outstanding

17,485,462

10 Years Aggregate

CFO

$-125.72 Mln

EBITDA

$-131.81 Mln

Net Profit

$-153.73 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Enlivex Therapeutics - ADR	-87.9	-34.4	-89.5	-91.9	-67.2	-62.9	-48.7
BSE Sensex^*	-8.9	-1.2	3.2	-3.3	6.0	6.0	10.5
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 31-Aug-2026 | *As on 01-Sep-2026 | #As on 26-Oct-2023

Company	2025	2023	2022	2021	2020	2019
Enlivex Therapeutics - ADR	-39.9	-31.4	-37.0	-25.9	0.5	35.6
S&P Small-Cap 600	4.0	13.9	-17.4	25.3	9.6	20.9
BSE Sensex	9.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Enlivex Therapeutics - ADR	1.3	23.6	0.0	1,235.5	--	126.2	0	0.0
CollPlant Biotechnologies - ADR	0.4	6.8	0.4	-13.1	-3,318.3	-185.1	--	1.1
Compugen - ADR	2.6	246.3	74.0	35.2	0.0	36.8	6.8	2.9
Evogene - ADR	0.5	8.7	1.3	-9.1	-1,029.8	--	--	6.2
Galmed Pharmaceuticals - ADR	4.1	4.3	0.0	-13.4	--	-90.4	--	0.3
Sol-Gel Technologies - ADR	69.1	225.3	1.8	-16.3	0.0	-46.1	--	4.9
UroGen Pharma (URGN)	43.1	2,132.2	188.7	-97.6	-38.6	--	--	19.3

Shareholding Pattern

View Details

About Enlivex Therapeutics - ADR

Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM... intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular AllocetraTM in osteoarthritis of the temporomandibular joint (TMJ); and Allocetra-OTS for the treatment of organ failure in adult sepsis patients, which is in phase 2. Enlivex Ltd. was formerly known as Enlivex Therapeutics Ltd. and changed its name to Enlivex Ltd. in February 2026. The company was founded in 2005 and is headquartered in Ness Ziona, Israel. Read more

Executive Chairman

Mr. Shai Novik M.B.A.
Executive Chairman

Mr. Shai Novik M.B.A.
Headquarters

Ness Ziona
Website

https://www.enlivex.com

FAQs for Enlivex Therapeutics - ADR

What is the current share price of Enlivex Therapeutics Ltd - ADR Today?

The share price of Enlivex Therapeutics Ltd - ADR is $1.28 (NASDAQ) as of 31-Aug-2026 16:00 EDT. Enlivex Therapeutics Ltd - ADR has given a return of -67.21% in the last 3 years.

What is the current PB & PE ratio of Enlivex Therapeutics Ltd - ADR?

Since, TTM earnings of Enlivex Therapeutics Ltd - ADR is negative, P/E ratio is not available.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	0.00	0.00
2024	-0.11	0.07
2023	-1.73	1.67
2022	-2.33	1.27
2021	-7.91	1.35

What is the 52 Week High and Low of Enlivex Therapeutics Ltd - ADR?

The 52-week high and low of Enlivex Therapeutics Ltd - ADR are Rs 27.15 and Rs 1.15 as of 01-Sep-2026.

What is the market cap of Enlivex Therapeutics Ltd - ADR?

Enlivex Therapeutics Ltd - ADR has a market capitalisation of $ 24 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Enlivex Therapeutics Ltd - ADR?

Before investing in Enlivex Therapeutics Ltd - ADR, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.